Evi-1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Evi-1 monoclonal antibodies for research focused on understanding Evi-1 protein function. Evi-1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Evi-1 is a zinc finger transcription factor that plays a critical role in hematopoiesis and is implicated in the regulation of gene expression during development. Dysregulation of Evi-1 has been associated with various cancers, making it a significant target for therapeutic intervention and biomarker discovery. Understanding Evi-1 function is essential for elucidating its contributions to oncogenesis and cellular differentiation. Researchers can explore Evi-1's role in cell signaling pathways and its impact on gene regulation. Advanced research techniques enable detailed investigation of Evi-1's molecular mechanisms and interactions with other cellular components. Current studies continue to reveal new insights about Evi-1's involvement in normal development and disease progression. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of Evi-1's role in human health and disease.